Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Brain Cancer
3 T deemed more beneficial than 1.5 T in brain tumor magnetic resonance imaging
February 14th, 2006
3 T was deemed more beneficial than 1.5 T in contrast-enhanced brain tumor magnetic resonance imaging. "The objective of this study was to compare the difference in lesion enhancement between 1.5 and 3 T using an extracellular gadolinium chelate in a rat brain glioma model. Five rats (CDF Fischer 344) with implanted C6/LacZ brain gliomas were evaluated using matched T1-weighted spin echo techniques and hardware configurations at 1.5 and 3 T. Serial imaging over 10 minutes after gadoteridol (ProHance) administration was performed," scientists in the United States reported. "Contrast enhancement (CE), signal-to-noise ratios (SNR) for brain and tumor,...
Source: Cancer Weekly (2006-02-14)
|
